YS Biopharma (YS) Stock Chart & Stock Price History → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free YS Stock Alerts $0.94 +0.14 (+17.50%) (As of 03:40 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media YS Biopharma Stock Price Performance5 Day Performance+27.41%1 Month Performance+6.82%3 Month Performance+124.08%6 Month Performance+66.37%Year-To-Date Performance+83.95%1 Year Performance-38.16% Receive YS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read YS Stock Chart for Wednesday, May, 8, 2024 YS Chart by TradingView YS Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$0.77$0.78+0.97%$0.82$0.7227,529 shs$72.59 million05/06/2024$0.74$0.77+4.70%$0.81$0.7334,180 shs$71.89 million05/03/2024$0.74$0.74-0.03%$0.77$0.7214,831 shs$68.66 million05/02/2024$0.75$0.74-1.60%$0.75$0.7025,309 shs$68.68 million05/01/2024$0.73$0.75+3.31%$0.77$0.7140,632 shs$69.80 million04/30/2024$0.77$0.73-5.71%$0.78$0.7054,115 shs$67.56 million Get the Latest News and Ratings for YS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$0.80$0.77-3.75%$0.84$0.7576,029 shs$71.66 million04/26/2024$0.80$0.80+0.63%$0.85$0.7739,764 shs$74.45 million04/25/2024$0.81$0.80-1.85%$0.85$0.7169,079 shs$73.98 million04/24/2024$0.81$0.81-0.11%$0.82$0.8024,318 shs$75.38 million04/23/2024$0.74$0.81+9.43%$0.82$0.7755,155 shs$75.46 million04/22/2024$0.73$0.74+2.15%$0.81$0.7187,203 shs$68.96 million04/19/2024$0.86$0.73-15.16%$0.88$0.70417,780 shs$67.51 million04/18/2024$0.94$0.86-8.65%$0.96$0.83354,272 shs$79.57 million04/17/2024$0.85$0.94+9.63%$0.96$0.80413,726 shs$87.10 million04/16/2024$0.89$0.85-4.07%$0.88$0.8345,905 shs$79.46 million04/15/2024$0.86$0.89+3.49%$0.92$0.83112,869 shs$82.82 million04/12/2024$0.86$0.86-0.57%$0.93$0.8356,970 shs$80.03 million04/11/2024$0.90$0.86-3.90%$0.93$0.8368,918 shs$80.49 million04/10/2024$0.85$0.90+5.88%$0.91$0.8299,053 shs$83.75 million04/09/2024$0.88$0.85-3.41%$0.90$0.83487,406 shs$79.10 million04/08/2024$0.88$0.88-0.19%$0.99$0.8553,649 shs$81.89 million04/05/2024$0.90$0.88-1.82%$0.95$0.8758,811 shs$82.05 million04/04/2024$0.84$0.90+6.65%$1.02$0.82499,241 shs$83.57 million04/03/2024$0.75$0.84+12.42%$0.85$0.75261,191 shs$78.36 million04/02/2024$0.73$0.75+3.31%$0.78$0.7178,434 shs$69.70 million04/01/2024$0.72$0.73+0.71%$0.78$0.70108,244 shs$67.47 million03/29/2024$0.72$0.72$0.73$0.6649,864 shs$66.99 million03/28/2024$0.71$0.72+1.39%$0.73$0.6649,501 shs$66.99 million03/27/2024$0.63$0.71+12.70%$0.77$0.60135,276 shs$66.07 million03/26/2024$0.65$0.63-3.08%$0.67$0.58245,636 shs$58.63 million03/25/2024$0.63$0.65+3.17%$0.66$0.6319,942 shs$60.49 million03/22/2024$0.63$0.63+0.57%$0.66$0.6199,720 shs$58.63 million03/21/2024$0.63$0.63-0.57%$0.70$0.62158,401 shs$58.29 million03/20/2024$0.64$0.63-0.80%$0.67$0.61110,933 shs$58.63 million03/19/2024$0.72$0.64-11.31%$0.71$0.61163,557 shs$59.10 million03/18/2024$0.72$0.72-0.95%$0.76$0.70241,828 shs$66.64 million03/15/2024$0.71$0.72+2.55%$0.75$0.6868,846 shs$67.28 million03/14/2024$0.74$0.71-4.73%$0.78$0.68188,229 shs$65.61 million03/13/2024$0.68$0.74+9.45%$0.82$0.71312,709 shs$68.86 millionThe Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>>03/12/2024$0.64$0.68+5.81%$0.79$0.57371,666 shs$62.92 million03/11/2024$0.63$0.64+1.75%$0.68$0.61122,261 shs$59.47 million03/08/2024$0.61$0.63+2.97%$0.64$0.6150,415 shs$58.44 million03/07/2024$0.64$0.61-4.55%$0.63$0.55228,413 shs$56.76 million03/06/2024$0.61$0.64+4.75%$0.72$0.55850,023 shs$59.47 million03/05/2024$0.46$0.61+32.46%$0.65$0.44699,469 shs$56.77 million03/04/2024$0.43$0.46+7.34%$0.46$0.42177,939 shs$42.85 million03/01/2024$0.38$0.43+12.89%$0.43$0.38765,771 shs$39.92 million02/29/2024$0.38$0.38$0.40$0.3874,744 shs$35.36 million02/28/2024$0.40$0.38-4.98%$0.42$0.38196,835 shs$35.36 million02/27/2024$0.40$0.40-0.03%$0.41$0.38152,966 shs$37.22 million02/26/2024$0.39$0.40+1.29%$0.44$0.38133,071 shs$37.22 million02/23/2024$0.41$0.39-2.69%$0.43$0.39185,526 shs$36.75 million02/22/2024$0.41$0.41-1.02%$0.46$0.40218,684 shs$37.76 million02/21/2024$0.39$0.41+4.33%$0.43$0.39338,647 shs$38.16 million02/20/2024$0.40$0.39-2.72%$0.47$0.39288,224 shs$36.57 million02/19/2024$0.40$0.40$0.42$0.38100,200 shs$37.60 million02/16/2024$0.42$0.40-3.42%$0.42$0.3999,903 shs$37.60 million02/15/2024$0.40$0.42+3.67%$0.44$0.40122,788 shs$38.93 million02/14/2024$0.41$0.40-2.54%$0.42$0.3963,625 shs$37.55 million02/13/2024$0.41$0.41+1.52%$0.43$0.4090,579 shs$38.53 million02/12/2024$0.42$0.41-2.67%$0.45$0.39124,381 shs$37.95 million02/09/2024$0.42$0.42-0.12%$0.47$0.39140,362 shs$38.99 million02/08/2024$0.40$0.42+4.61%$0.44$0.38170,147 shs$39.04 million02/07/2024$0.39$0.40+4.16%$0.41$0.36123,824 shs$37.32 million Related Companies: Rallybio Stock Chart Landos Biopharma Stock Chart MediciNova Stock Chart SCYNEXIS Stock Chart Viveon Health Acquisition Stock Chart Carisma Therapeutics Stock Chart vTv Therapeutics Stock Chart Journey Medical Stock Chart Mural Oncology Stock Chart Assembly Biosciences Stock Chart Receive YS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:YS) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YS Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.